STAAR Surgical Eyes Market Expectations | Business and Finance News

STAAR Surgical is set to drop its Q2 earnings this Wednesday, riding a wave of momentum after last quarter’s stunning 120% revenue surge—far exceeding analyst forecasts. With the market now expecting another 104% YoY growth and analysts holding steady despite past misses, STAAR faces high expectations. While peers like Inspire and Integer beat estimates and saw stock gains, STAAR’s shares have lagged, down 8.9% in the last month despite sector-wide gains. At $25.31, the stock trades below analyst targets of $28.70—making this report a pivotal moment to see if they can sustain their explosive growth. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/c803b3b7cf69cb43